Baseline SYNTAX Score and Long-Term Outcome in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Clinical and Applied Thrombosis/Hemostasis

Volumn 21, Issue 8, 2015, Pages 712-719

  Akgun, Taylan ^a   Oduncu, Vecih ^b   Bitigen, Atila ^c   Karabay, Can Yucel ^a   Erkol, Ayhan ^a   Kocabay, Gonenc ^a   Ozveren, Olcay ^a   Yildiz, Abdulmelik ^b   Cimen, Arif Oguzhan ^b   Kirma, Cevat ^a  

^a KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

^b Medical Park Fatih Hospital   (Turkey)

^c BAHCESEHIR UNIVERSITY   (Turkey)

Author keywords

acute coronary syndromes; mortality; SYNTAX score

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN I; URIC ACID; GLUCOSE BLOOD LEVEL;

ADULT; AGE DISTRIBUTION; ANEMIA; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CHRONIC TOTAL OCCLUSION; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL READMISSION; HUMAN; INCIDENCE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVESSEL DISEASE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROXIMAL LESION LOCALIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYNTAX SCORE; VASCULAR DISEASE; AGED; BLOOD; CLINICAL TRIAL; CORONARY ANGIOGRAPHY; DISEASE FREE SURVIVAL; GLUCOSE BLOOD LEVEL; METABOLISM; MORTALITY; MYOCARDIAL INFARCTION; RADIOGRAPHY; SURVIVAL RATE;

AGED; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; CREATININE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; SURVIVAL RATE;

EID: 84943277154     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029614521281     Document Type: Article

References (21)

1. Raber L, Kelbak H, Ostojic M, et al. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. JAMA. 2012; 308 (8): 777-787.
2. Brodie BR, Stuckey TD, Hansen C, Muncy D,. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol. 2000; 85 (1): 13-18.
3. Morrow DA, Antman EM, Charlesworth A, et al. TIMI Risk Score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. Circulation. 2000; 102 (17): 2031-2037.
4. Addala S, Grines CL, Dixon SR, et al. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol. 2004; 93 (5): 629-632.
5. Oduncu V, Erkol A, Karabay CY, et al. Relation of the severity of contrast induced nephropathy to SYNTAX score and long term prognosis in patients treated with primary percutaneous coronary intervention. Int J Cardiol. 2013; 168 (4): 3480-3485.
6. Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study. Eurointervention. 2009; 5 (1): 50-56.
7. Can MM, Tanboga H, Karabay CY, et al. The treatment of acute myocardial infarction due to the occlusion of the left main coronary disease. Cardiol J. 2011; 18 (1): 77-82.
8. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention. 2005; 1 (2): 219-227.
9. De Lemos JA, Braunwald E,. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol. 2001; 38 (5): 1283-1294.
10. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr. 2005; 18 (12): 1440-1463.
11. Rao AK, Pratt C, Berke A, et al. Thrombolysis in myocardial infarction (TIMI) trial-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol. 1988; 11 (1): 1-11.
12. Vant Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F,. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle myocardial infarction study group. Circulation. 1998; 97 (23): 2302-2306.
13. Steg PG, James SK, Atar D, Badano LP, et al. Task Force on the management of ST-segment elevation acute myocardial infarction of the European society of cardiology (ESC), ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33 (20): 2569-2619.
14. Oduncu V, Erkol A, Turan B, et al. Predictors and long-term prognostic significance of angiographically distal embolization during primary percutaneous coronary intervention. Turk Kardiyol Dern Ars. 2013; 41 (6): 486-494.
15. Biondi-Zoccai G, Lotrionte M, Sheiban I,. Management of multivessel coronary disease after ST-elevation myocardial infarction treated by primary coronary angioplasty. Am Heart J. 2010; 160 (suppl 6): S28-S35.
16. Brown AJ, McCormick LM, Gajendragadkar PR, Hoole SP, West NE,. Initial SYNTAX score predicts major adverse cardiac events after primary percutaneous coronary intervention. Angiology. 2013; 65 (5): 408-412.
17. Ahin DY, Gür M, Elbasan Z, et al. SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention. Coron Artery Dis. 2013; 24 (2): 148-153.
18. Nam CW, Mangiacapra F, Entjes R, et al. FAME study investigators. functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol. 2011; 58 (12): 1211-1218.
19. Farooq V, Vergouwe Y, Räber L, et al. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the logistic clinical SYNTAX score. Eur Heart J. 2012; 33 (24): 3098-3104.
20. Farooq V, Serruys PW, Bourantas CV, et al. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation. 2013; 128 (2): 141-151.
21. Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013; 369 (12): 1115-1123.